granted
on 18 Oct 2023
Last Applicant/ Owned by
1718 Ringwood Avenue
San Jose
CA
95131
Serial Number
90157600 filed on 03rd Sep 2020
Registration Number
N/A
Correspondent Address
Bret E. Field BOZICEVIC, FIELD & FRANCIS LLP
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
The color(s) light blue and dark blue is/are claimed as a feature of the mark. Cosmetics; cosmetic preparations; adhesives for cosmetic purposes; cosmetic masks; non-medicated soaps for personal use; perfumery; essential oils; hair lotions Pharmaceuticals for the treatment of cardiovascular conditions, allergies, central nervous system conditions, peripheral nervous system conditions, electrolytRead More
Pharmaceuticals for the treatment of cardiovascular conditions, allergies, central nervous system conditions, peripheral nervous system conditions, electrolytic imbalance, caloric imbalance, obesity, vitamin imbalance, gastrointestinal conditions, inflammation, dermatological conditions, infectious diseases, hormonal imbalance, pain, cancer conditions, pulmonary conditions, ophthalmic conditions, musculoskeletal conditions, diabetic conditions, psychosis, senile conditions, dementia, congenital disease conditions, abnormal gene conditions; pharmaceutical preparations, compositions, creams and lotions for the treatment of cardiovascular conditions, allergies, central nervous system conditions, peripheral nervous system conditions, electrolytic imbalance, caloric imbalance, obesity, vitamin imbalance, gastrointestinal conditions, inflammation, dermatological conditions, infectious diseases, hormonal imbalance, pain, cancer conditions, pulmonary conditions, ophthalmic conditions, musculoskeletal conditions, diabetic conditions, psychosis, senile conditions, dementia, congenital disease conditions, abnormal gene conditions; prescription and over-the-counter pharmaceutical preparations for the treatment of cardiovascular conditions, allergies, central nervous system conditions, peripheral nervous system conditions, electrolytic imbalance, caloric imbalance, obesity, vitamin imbalance, gastrointestinal conditions, inflammation, dermatological conditions, infectious diseases, hormonal imbalance, pain, cancer conditions, pulmonary conditions, ophthalmic conditions, musculoskeletal conditions, diabetic conditions, psychosis, senile conditions, dementia, congenital disease conditions, abnormal gene conditions; prescription and over-the-counter pharmaceutical preparations, namely, transdermal gel formulations, transdermal cream formulations, oral mucous formulations, transdermal patches, dressings and medical adhesive tapes for use in the treatment of cardiovascular conditions, allergies, central nervous system conditions, peripheral nervous system conditions, electrolytic imbalance, caloric imbalance, obesity, vitamin imbalance, gastrointestinal conditions, inflammation, dermatological conditions, infectious diseases, hormonal imbalance, pain, cancer conditions, pulmonary conditions, ophthalmic conditions, musculoskeletal conditions, diabetic conditions, psychosis, senile conditions, dementia, congenital disease conditions, abnormal gene conditions
11th 000101
11th 000101
Cosmetics; cosmetic preparations; adhesives for cosmetic purposes; cosmetic masks; non-medicated soaps for personal use; perfumery; essential oils; hair lotions
11th 000101
11th 000101
No 90157600
No Service/Collective Mark
No TEIK-T039
No
No
No
No
No
No
No
No
24.17.06 -
Plus symbol (+)
26.01.21 -
Circles that are totally or partially shaded
26.01.31 -
Five or more circles
The mark consists of the word, "EksterMed" with "Ekster" in dark blue and "Med" in lighter blue. Above the wording is a design consisting of seventy-five small circles lined both horizontally and vertically, forming a shape of a plus symbol. The size of the circles is large in the inner part and dark blue and the circles become light blue and smaller toward the outer part.
| Status Date | Action Taken |
|---|---|
| 19th Oct 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 18th Oct 2023 | SOU EXTENSION 5 GRANTED |
| 16th Oct 2023 | SOU EXTENSION 5 FILED |
| 16th Oct 2023 | SOU TEAS EXTENSION RECEIVED |
| 19th Apr 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 17th Apr 2023 | SOU EXTENSION 4 GRANTED |
| 17th Apr 2023 | SOU EXTENSION 4 FILED |
| 17th Apr 2023 | SOU TEAS EXTENSION RECEIVED |
| 19th Oct 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 17th Oct 2022 | SOU EXTENSION 3 GRANTED |
